F4/80+Ly6C高表达巨噬细胞导致结肠炎中的细胞可塑性与癌症起始
该研究在小鼠结肠炎相关癌症模型中比较了多种结肠炎形式,发现仅DSS结肠炎可重复诱导结肠肿瘤,其特点为CD11b+F4/80+Ly6C高表达巨噬细胞和CD11b+Ly6G+中性粒细胞显著增加;清除CD11b+F4/80+Ly6C高表达巨噬细胞可抑制肿瘤发生,而清除中性粒细胞无影响,巨噬细胞来源的IL-1β、TNF-α和IL-6促进Dclk1+簇细胞干性。
要点
- DSS结肠炎可重复诱导两种小鼠模型发生结肠肿瘤,其他形式结肠炎未导致癌症。
- DSS结肠炎中CD11b+F4/80+Ly6C高表达巨噬细胞和CD11b+Ly6G+中性粒细胞显著增加。
- 清除CD11b+F4/80+Ly6C高表达巨噬细胞抑制肿瘤发生,清除中性粒细胞无影响。
核心结论
- CD11b+F4/80+Ly6C高表达巨噬细胞是结肠炎相关癌症起始的关键介质。
- 作者认为靶向这些细胞的新疗法可能为结肠炎相关癌症提供有效的预防策略。
研究设计与样本
- 研究比较了多种小鼠结肠炎模型(DSS、2,4,6-三硝基苯磺酸、4-乙氧基亚甲基-2-苯基恶唑-5-酮、啮齿柠檬酸杆菌、具核梭杆菌和多柔比星)导致结肠肿瘤发生的能力。
- 在氧化偶氮甲烷依赖性和Dclk1/APCfl/fl两种小鼠结肠炎相关癌症模型中,分析结肠炎严重程度和炎症特征与肿瘤发生风险的相关性。
主要发现
- DSS结肠炎在两种小鼠结肠炎相关癌症模型中均可重复导致结肠肿瘤,而所有其他形式的结肠炎均未导致癌症。
- 与未伴随肿瘤发生的结肠炎相比,DSS结肠炎的特征是CD11b+F4/80+Ly6C高表达巨噬细胞和CD11b+Ly6G+中性粒细胞显著增加。
- 清除CD11b+F4/80+Ly6C高表达巨噬细胞可抑制肿瘤发生,而清除CD11b+Ly6G+中性粒细胞对肿瘤发生无影响。
- 巨噬细胞来源的细胞因子白细胞介素-1β、肿瘤坏死因子-α和白细胞介素-6在DSS结肠炎中显著增加,并促进作为癌症细胞起源的Dclk1+簇细胞的干性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Colorectal cancer is a leading cause of cancer death, and a major risk factor is chronic inflammation. Despite the link between colitis and cancer, the mechanism by which inflammation leads to colorectal cancer is not well understood. METHODS: To investigate whether different forms of inflammation pose the same risk of cancer, we compared several murine models of colitis (dextran sodium sulfate [DSS], 2,4,6-trinitrobenzene sulfonic acid, 4-ethoxylmethylene-2-phenyloxazol-5-one, Citrobacter rodentium, Fusobacterium nucleatum, and doxorubicin) with respect to their ability to lead to colonic tumorigenesis. We attempted to correlate the severity of colitis and inflammatory profile with the risk of tumorigenesis in both azoxymethane-dependent and Dclk1/APCfl/fl murine models of colitis-associated cancer. RESULTS: DSS colitis reproducibly led to colonic tumors in both mouse models of colitis-associated cancer. In contrast, all other forms of colitis did not lead to cancer. When compared with the colitis not associated with tumorigenesis, DSS colitis was characterized by significantly increased CD11b+F4/80+Ly6Chigh macrophages and CD11b+Ly6G+ neutrophils. Interestingly, depletion of the CD11b+F4/80+Ly6Chigh macrophages inhibited tumorigenesis, whereas depletion of CD11b+Ly6G+ neutrophils had no effect on tumorigenesis. Furthermore, the macrophage-derived cytokines interleukin-1β, tumor necrosis factor-α, and interleukin-6 were significantly increased in DSS colitis and promoted stemness of Dclk1+ tuft cells that serve as the cellular origin of cancer. CONCLUSIONS: We have identified CD11b+F4/80+Ly6Chigh macrophages as key mediators of cancer initiation in colitis-associated cancer. Development of new therapies that target these cells may provide an effective preventative strategy for colitis-associated cancer.
引用
- Shin AE, Tesfagiorgis Y, Larsen F, et al. F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis. Gastroenterology. 2023. PMID: 36634827. doi:10.1053/j.gastro.2023.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。